Autologe hämatopoetische Stammzelltransplantation als Therapieoption bei hochaktiver MS
Crossref DOI link: https://doi.org/10.1007/s42451-024-00629-4
Published Online: 2024-02-01
Published Print: 2024-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lauks, S.
Text and Data Mining valid from 2024-02-01
Version of Record valid from 2024-02-01
Article History
Accepted: 9 January 2024
First Online: 1 February 2024